Table 3.

Immunohistochemistry baseline patterns identified for the cases where efficacy data were obtained

CaseEGFRpEGFRPMAPKpAkt
Learning set
    198++++++
    410++++++
    286++++
    140+
    163+
    287++
    253++
    194+
    265+++++
    215+++
Validation set
    219++++
    294++
    281++
    247++++
    185++++
    159+++
    354+++
    420++++
  • NOTE: Sensitive cases are shown in bold.